ITGB1 and non-small cell lung carcinoma: Liang et al. confirmed that ITGB1 is a target of miR-493-5p and that NSCLC patients with high expression of ITGB1 and low expression of miR-493-5p have a shorter survival period and poorer prognosis than those with other expression patterns [30].